Clinical Trials Directory

Trials / Completed

CompletedNCT01431235

CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders

Investigating the Efficacy of Cognitive Behavioral Therapy in Patients With Substance Use Disorder and Comorbid ADHD. A Randomized Controlled Trial With Cognitive Behavioral Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
184 (actual)
Sponsor
Arkin · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.

Detailed description

Attention Deficit Hyperactivity Disorder(ADHD) is an important comorbid condition in patients with substance use disorders (SUD). The prevalence of ADHD in patients with SUD is estimated 23%, and ADHD is associated with an untoward prognosis of SUD. However, adequate treatment programs for patients with ADHD and SUD are not available. Results of medication trials for patients with ADHD and SUD are disappointing, and cognitive behavioral therapy (CBT) has not yet been investigated in this population. In patients with ADHD without comorbid SUD, the results of CBT in randomized trials are positive. The purpose of this study is to investigate if CBT is effective in treating ADHD symptoms in patients with ADHD and SUD.

Conditions

Interventions

TypeNameDescription
BEHAVIORALcognitive behavioral therapy for treating ADHD symptoms5 sessions of one hour CBT for treating ADHD symptoms by a trained health care worker

Timeline

Start date
2011-08-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2011-09-09
Last updated
2017-01-16

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01431235. Inclusion in this directory is not an endorsement.